RAFAEL HOLDINGS, INC. Other Accounts Payable and Accrued Liabilities
RAFAEL HOLDINGS, INC. (RFL) had Other Accounts Payable and Accrued Liabilities of $3.80 million as of 2025-10-31, per its 10-Q filed 2025-12-12.
Financial Statements › Notes › Payables and Accruals
us-gaap:OtherAccountsPayableAndAccruedLiabilities · last filed 2025-12-12
- 2025-10-31: Other Accounts Payable and Accrued Liabilities $3.80M.
- 2025-07-31: Other Accounts Payable and Accrued Liabilities $3.60M.
- 2024-07-31: Other Accounts Payable and Accrued Liabilities $3.00M.
| Period end | Other Accounts Payable and Accrued Liabilities |
|---|---|
| 2025-10-31 | $3.80M 10-Q · filed 2025-12-12 |
| 2025-07-31 | $3.60M 10-Q · filed 2025-12-12 |
| 2024-07-31 | $3.00M 10-K · filed 2025-10-29 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Aditxt, Inc. (ADTX) | United States | $0.000B | |
| CDT Equity Inc. (CDT) | United States | $0.000B | -0.01 |
| Protagenic Therapeutics, Inc.\new (PTIX) | United States | $0.001B | |
| Decoy Therapeutics Inc. (DCOY) | United States | $0.002B | -0.27 |
| Nexentis Technologies Inc. (NXTS) | $0.002B | ||
| ORAGENICS INC (OGEN) | United States | $0.002B | |
| JUPITER NEUROSCIENCES, INC. (JUNS) | United States | $0.002B | -0.02 |
| BioXcel Therapeutics, Inc. (BTAI) | United States | $0.002B | |
| ZyVersa Therapeutics, Inc. (ZVSA) | United States | $0.002B | |
| Matinas BioPharma Holdings, Inc. (MTNB) | United States | $0.003B |